Transport measurements across Caco-2 monolayers of different organic and inorganic selenium: influence of sulfur compounds.
The transport and uptake of the most common Se compounds, selenate (SeO42-), selenite (SeO3(2-)), selenomethionine, and selenocystine, were investigated using confluent monolayers of Caco-2 cells, a human carcinoma cell line. Comparative measurements were performed in the absorptive (apical to basolateral side) and exsorptive (basolateral to apical side) directions. Apparent permeability coefficients (Papp), calculated from transport experiments in the absorptive direction, showed increasing values in the following rank order: about 1 x 10(6) cm/s < mannitol < SeO3(2-) < or = selenocystine < selenomethionine < SeO4(2-) < or = about 16 x 10(4) cm/s. The ratios of the Papp measured in the absorptive versus exsorptive directions indicated that only the organic forms presented a net polarized transport (Papp ratio >> 1), suggesting the presence of a transcellular pathway. No significant excretion was observed. The transport of selenomethionine was inhibited by its sulfur analog, methionine, suggesting a common transport mechanism. In contrast, an inhibition of the transport of selenocystine by cysteine was not observed. From the two substrates tested, sulfate and thiosulfate, only thiosulfate inhibited the transport of SeO4(2-) . This effect was also observed for SeO32- (i.e., was unspecific), which questioned the assertion of a common transport for sulfate and SeO4(2-) and may confirm the paracellular pathway of SeO42- suggested by the Papp ratio of about 1. The addition of glutathione (GSH) in large excess had no consequence on the passage of SeO3(2-) but strongly increased the uptake (about fourfold). The liquid chromatography - mass spectrometry (LC-MS) data showed that, in the ionic condition of incubation medium, GSH promptly reduced SeO3(2-) (< or = 2 min) in its elemental form Se0, which cannot ascribe to selenodiglutathione a direct role in the effect of GSH.
Leblondel
G
G
Laboratory of Pharmacology and Toxicology, University Hospital, Angers, France.
Mauras
Y
Y
Cailleux
A
A
Allain
P
P
D001692:Biological Transport; D018938:Caco-2 Cells; D003545:Cysteine / Q000378:metabolism; D003553:Cystine / Q000031:analogs & derivatives* / Q000378:metabolism; D005978:Glutathione / Q000378:metabolism; D006801:Humans; D007413:Intestinal Mucosa / Q000378:metabolism; D008353:Mannitol / Q000493:pharmacokinetics; D008715:Methionine / Q000378:metabolism; D016566:Organoselenium Compounds / Q000378:metabolism; D064586:Selenic Acid; D012643:Selenium / Q000378:metabolism* / Q000493:pharmacokinetics; D018036:Selenium Compounds / Q000378:metabolism* / Q000493:pharmacokinetics; D012645:Selenomethionine / Q000378:metabolism; D013431:Sulfates / Q000378:metabolism; D014407:Tumor Cells, Cultured
D016566:Organoselenium Compounds; D018036:Selenium Compounds; D013431:Sulfates; C009226:selenocystine; D008353:Mannitol; D003553:Cystine; D012645:Selenomethionine; D008715:Methionine; D005978:Glutathione; D012643:Selenium; D064586:Selenic Acid; D003545:Cysteine